These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 10738609
41. Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instrument? Neuman HB, Schrag D, Cabral C, Weiser MR, Paty PB, Guillem JG, Minsky BD, Wong WD, Temple LK. Ann Surg Oncol; 2007 May; 14(5):1727-34. PubMed ID: 17265117 [Abstract] [Full Text] [Related]
42. Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy. Yoshimura R, Shibuya H, Miura M, Watanabe H, Ayukawa F, Hayashi K, Toda K. Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):772-8. PubMed ID: 18676096 [Abstract] [Full Text] [Related]
45. The European Organization for Research and Treatment of Cancer quality of life questionnaire: translation and reliability study of the Thai version. Sirisinha T, Ratanatharathorn V, Jirajarus M, Sirilerttrakul S, Silpakit C, Sirachainan E, Tanvetyanon T. J Med Assoc Thai; 2002 Nov 01; 85(11):1210-9. PubMed ID: 12546319 [Abstract] [Full Text] [Related]
47. Changes in quality of life of head-and-neck cancer patients following postoperative radiotherapy. Fang FM, Chien CY, Kuo SC, Chiu HC, Wang CJ. Acta Oncol; 2004 Nov 01; 43(6):571-8. PubMed ID: 15370615 [Abstract] [Full Text] [Related]
48. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites. Easson AM, Bezjak A, Ross S, Wright JG. Ann Surg Oncol; 2007 Aug 01; 14(8):2348-57. PubMed ID: 17505860 [Abstract] [Full Text] [Related]
51. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY, Suen JY. Arch Otolaryngol Head Neck Surg; 2004 Jul 01; 130(7):875-9. PubMed ID: 15262766 [Abstract] [Full Text] [Related]
55. Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module. Winstanley JB, Young TE, Boyle FM, Bergenmar M, Bottomley A, Burmeister B, Campana LG, Garioch JJ, King M, Nikolic DV, van de Poll-Franse LV, Saw R, Thompson JF, White EG, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group. Melanoma Res; 2015 Feb 01; 25(1):47-58. PubMed ID: 25325247 [Abstract] [Full Text] [Related]
56. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Blazeby JM, Alderson D, Winstone K, Steyn R, Hammerlid E, Arraras J, Farndon JR. Eur J Cancer; 1996 Oct 01; 32A(11):1912-7. PubMed ID: 8943674 [Abstract] [Full Text] [Related]
57. What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire. Winstanley JB, White EG, Boyle FM, Thompson JF. Melanoma Res; 2013 Apr 01; 23(2):167-74. PubMed ID: 23358427 [Abstract] [Full Text] [Related]
58. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21. Friend E, Yadegarfar G, Byrne C, Johnson CD, Sezer O, Pucciarelli S, Pereira SP, Chie WC, Banfield A, Ramage JK, EORTC Quality of Life Group. Br J Cancer; 2011 Feb 15; 104(4):587-92. PubMed ID: 21266979 [Abstract] [Full Text] [Related]